AC Immune SA (ACIU)

NGM – Real Time Price. Currency in USD

2.60

+0.06 (2.36%)

Market open: Aug 12, 2026, 2:47 PM EDT

2.54

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

05.08.2026

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune (ACIU) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to a loss of $0.25 per share a year ago.

05.08.2026

AC Immune First Half 2026 Financial and Corporate Update

AC Immune First Half 2026 Financial and Corporate Update Focused portfolio of wholly-owned programs approach near-term clinical catalysts as partnered programs generate milestone payments Key advances across pipeline, with further near-term clinical results anticipated for H2 2026 Phase 2 VacSYn trial of ACI-7104 in Parkinson's disease supported by a $4 million grant from The Vijay and Marie Goradia Charitable Foundation Morphomer small molecule program targeting intracellular Tau progresses with Lilly Initiation of Alzheimer's disease AD4 cohort in ABATE trial triggered $12 million milestone payment from Takeda Cash resources of CHF 75.4 million as of June 30, 2026, provide funding into Q4 2027 Lausanne, Switzerland, August 5, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company developing targeted therapeutics for neurodegenerative diseases, today provided a corporate and financial update for the half-year ended June 30, 2026. Martin Zügel, MD, interim CEO of AC Immune and Chair of the Board of Directors, commented: “AC Immune is moving towards key clinical milestones in two of our wholly-owned programs, a growing focus for AC Immune.

Videos

No Data

There is no data to display

Press releases

05.08.2026

AC Immune SA (ACIU)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AC Immune SA (ACIU)

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune First Half 2026 Financial and Corporate Update

Videos

No Data

Press releases

AC Immune First Half 2026 Financial and Corporate Update

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune First Half 2026 Financial and Corporate Update

Videos

No Data

Press releases

AC Immune First Half 2026 Financial and Corporate Update

Search stocks

AC Immune SA (ACIU)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AC Immune SA (ACIU)

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune First Half 2026 Financial and Corporate Update

Videos

No Data

Press releases

AC Immune First Half 2026 Financial and Corporate Update

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

AC Immune First Half 2026 Financial and Corporate Update

Videos

No Data

Press releases

AC Immune First Half 2026 Financial and Corporate Update